Sage Therapeutics, Inc. Human Resources Contracts & Agreements
28 Contracts & Agreements
- Bonus & Incentive Agreements (7 contracts)
- Change of Control Agreements (8)
- Compensation Agreements (6)
- Consulting Agreements (1)
- Non-Competition Agreements (4)
- Separation Agreements (2)
- Non-Employee Director Compensation Program, adopted June 10, 2024 (Filed With SEC on July 31, 2024)
- Form of Non-Employee Director Option Agreement under the 2024 Equity Incentive Plan (Filed With SEC on July 31, 2024)
- Form of Restricted Stock Unit Agreement under the 2024 Equity Incentive Plan (Filed With SEC on July 31, 2024)
- Form of Option Agreement under the 2024 Equity Incentive Plan (Filed With SEC on July 31, 2024)
- 2024 Equity Incentive Plan (Filed With SEC on July 31, 2024)
- Master Consulting Agreement and Statement of Work between the Registrant and Albert J. Robichaud, Ph.D., dated September 15, 2023 (Filed With SEC on November 7, 2023)
- Separation Agreement between the Registrant and Albert J. Robichaud, Ph.D., dated September 15, 2023 (Filed With SEC on November 7, 2023)
- Amended and Restated Non-Employee Director Compensation Policy, dated April 8, 2022 (Filed With SEC on August 2, 2022)
- Severance and Change in Control Agreement between the Registrant and Christopher Benecchi, dated September 13, 2021 (Filed With SEC on November 2, 2021)
- Separation Agreement, by and between the Registrant and Michael Cloonan, dated March 12, 2021 (Filed With SEC on May 4, 2021)
- Form of Performance-Based Restricted Stock Unit Award Agreement Under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan (Filed With SEC on August 10, 2020)
- Amended and Restated Non-Employee Director Compensation Policy, dated as of September 20, 2018 (Filed With SEC on November 6, 2018)
- Amended and Restated Non-Employee Director Compensation Plan, dated as of March 30, 2018 (Filed With SEC on May 3, 2018)
- Sage Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on November 2, 2017)
- Severance and Change in Control Agreement between the Registrant and Michael Cloonan, dated March 21, 2017 (Filed With SEC on August 3, 2017)
- SAGE Therapeutics, Inc. Amended and Restated Non-Employee Director Compensation Policy (Filed With SEC on February 24, 2017)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on March 6, 2015)
- SEVERANCE AND CHANGE IN CONTROL AGREEMENT (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. SENIOR EXECUTIVE CASH INCENTIVE BONUS PLAN (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. Employee Non-Competition, Non-Solicitation, Confidentiality and Assignment Agreement (Filed With SEC on July 8, 2014)
- SAGE THERAPEUTICS, INC. 2014 STOCK OPTION AND INCENTIVE PLAN (Filed With SEC on July 8, 2014)
